Zobrazeno 1 - 10
of 82
pro vyhledávání: '"J. A. Himes"'
Autor:
Jinshan Shen, Jiayin Huang, Licong Jiang, Sarah Robertson, Linda T Wang, J Lekstrom-Himes, Kristin Stephan, Sagar Agarwal, Varun Garg, Linda Han, Asfiha Gebre, Chonghua Li
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 3, Pp 267-275 (2019)
Clinical and Translational Science
Clinical and Translational Science
Drug-drug interaction (DDI) studies are described for tezacaftor/ivacaftor, a new cystic fibrosis transmembrane conductance regulator modulator therapy for the treatment of cystic fibrosis. Three phase I DDI studies were conducted in healthy subjects
Autor:
Yimeng Lu, Markus Y. Mapara, Niraj Shanbhag, Damiano Rondelli, Franco Locatelli, C. Fernández, Sandeep Soni, Donna A. Wall, Yael Bobruff, John K. Wu, Stephan A. Grupp, Sarah D. Mulcahey, Sujit Sheth, Haydar Frangoul, Antonis Kattamis, Maria Domenica Cappellini, Tony W. Ho, J Lekstrom-Himes, Mariane de Montalembert, Martin H. Steinberg, Selim Corbacioglu, Josu de la Fuente, Rupert Handgretinger, Michael J. Weinstein, Suzan Imren
Publikováno v:
Transplantation and Cellular Therapy. 27:S72-S73
Autor:
Antonis Kattamis, Maria Domenica Cappellini, Martin H. Steinberg, Franco Locatelli, Josu de la Fuente, Sandeep Soni, Damiano Rondelli, Suzan Imren, Sujit Sheth, Tony W. Ho, Stephan A. Grupp, Yimeng Lu, Michael J. Weinstein, Donna A. Wall, Markus Y. Mapara, John K. Wu, Yael Bobruff, Haydar Frangoul, Rupert Handgretinger, Selim Corbacioglu, Sarah D. Mulcahey, J Lekstrom-Himes, Mariane de Montalembert, Niraj Shanbhag, C. Fernández
Publikováno v:
Blood. 136:3-4
Background: BCL11A is a key transcription factor that suppresses the production of fetal hemoglobin (HbF) in red blood cells (RBCs), leading to the production of adult Hb (HbA). In diseases with hemoglobin production defects such as b-thalassemia, or
Autor:
JS Elborn, O Sommerburg, X You, Y Yang, R Rendas-Baum, M Kosinski, B Loop, J Lekstrom-Himes, AA Rizio
Publikováno v:
60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..
Autor:
R Rendas-Baum, Steven M. Rowe, M Kosinski, C-C Chuang, X You, B Loop, J Lekstrom-Himes, Jane C. Davies, Y Yang, AA Rizio
Publikováno v:
Cystic fibrosis: correctors and potentiators.
Introduction and objectives To examine the treatment effect of TEZ/IVA on disease-related symptoms, functioning, and well-being as measured by Cystic Fibrosis Questionnaire–Revised (CFQ-R) in patients heterozygous for F508del and a second allele wi
Publikováno v:
Cystic fibrosis: correctors and potentiators.
Introduction and objectives Tezacaftor/Ivacaftor (TEZ/IVA), a new CFTR modulator combination, improves forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) in patients aged ≥12 years with CF homozygous for F508del-CFTR (F/F; EVOLV
Autor:
R Rendas-Baum, AA Rizio, J Lekstrom-Himes, B Loop, M Kosinski, JS Elborn, X You, C-C Chuang, A Sole, Jennifer L. Taylor-Cousar, Y Yang
Publikováno v:
Cystic fibrosis: correctors and potentiators.
Introduction and objectives To examine the impact of TEZ/IVA on disease-related symptoms, functioning, and well-being as measured by Cystic Fibrosis Questionnaire–Revised (CFQ-R) in patients with cystic fibrosis (CF) homozygous for F508del-CFTR (F5
Autor:
Caroline A. Owen, Daniel Campbell, J. Lekstrom-Himes, A. Brody, Claire E. Wainwright, Linda T Wang, L.T. Wang, J. Goldin, S. Stick, R.S. Harris
Publikováno v:
Journal of Cystic Fibrosis. 18:S11-S12
Publikováno v:
Journal of Cystic Fibrosis. 17:S65-S66
Autor:
Patrick A. Flume, H. Zhou, K. De Boeck, J. Lekstrom-Himes, Christopher Simard, Damian G. Downey, R. Fischer Biner, Caroline A. Owen
Publikováno v:
Journal of Cystic Fibrosis. 17:S64-S65